Cargando…

Efficacy and safety of a modified lateral lumbar interbody fusion in L4-5 lumbar degenerative diseases compared with traditional XLIF and OLIF: a retrospective cohort study of 156 cases

BACKGROUND: The authors designed a modified lateral lumbar interbody fusion (LLIF) procedure named as XOLIF and compared the efficacy and safety with traditional LLIF procedures. METHODS: Patients were divided into XLIF, OLIF, and XOLIF group according to the surgical approach. Cases of psoas major...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiaqi, Sun, Yapeng, Guo, Lei, Zhang, Fei, Ding, Wenyuan, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903737/
https://www.ncbi.nlm.nih.gov/pubmed/35255886
http://dx.doi.org/10.1186/s12891-022-05138-7
_version_ 1784664835858890752
author Li, Jiaqi
Sun, Yapeng
Guo, Lei
Zhang, Fei
Ding, Wenyuan
Zhang, Wei
author_facet Li, Jiaqi
Sun, Yapeng
Guo, Lei
Zhang, Fei
Ding, Wenyuan
Zhang, Wei
author_sort Li, Jiaqi
collection PubMed
description BACKGROUND: The authors designed a modified lateral lumbar interbody fusion (LLIF) procedure named as XOLIF and compared the efficacy and safety with traditional LLIF procedures. METHODS: Patients were divided into XLIF, OLIF, and XOLIF group according to the surgical approach. Cases of psoas major and vascular space stenosis, psoas major muscle elevation, psoas major muscle hypertrophy, and high iliac crest were recorded. Basic information, composition ratio of specific cases, Visual analog scale (VAS), Oswestry Disability Index (ODI), interbody fusion rate and complications were compared between the 3 groups. RESULTS: The study included 156 cases of L4-5 LLIF. There was no statistical difference in age, gender, BMI among the three groups. Cases with stenosis between psoas muscle and artery accounted for 11.8 and 18.4% of the XLIF and XOLIF group, respectively, while no case of this type had undergone OLIF surgery, the difference was statistically significant (P < 0.05). The proportions of high iliac crest cases in the OLIF and XOLIF group were 12.5 and 18.4%, respectively, while the XLIF group with vertical approach is not suitable for cases with high iliac crest. The postoperative VAS and ODI of the three groups were significantly improved compared with those before operation. There were 51 cases (32.7%) of complications including 21cases in XLIF group, 20 cases in OLIF Group and 10 cases in XOLIF group. XOLIF group has more advantages in reducing lumbar plexus injury and the risk of vascular injury. CONCLUSIONS: XOLIF showed good clinical efficacy and technical advantages with a low incidence of intraoperative and postoperative complications, especially in the specific cases.
format Online
Article
Text
id pubmed-8903737
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89037372022-03-18 Efficacy and safety of a modified lateral lumbar interbody fusion in L4-5 lumbar degenerative diseases compared with traditional XLIF and OLIF: a retrospective cohort study of 156 cases Li, Jiaqi Sun, Yapeng Guo, Lei Zhang, Fei Ding, Wenyuan Zhang, Wei BMC Musculoskelet Disord Research Article BACKGROUND: The authors designed a modified lateral lumbar interbody fusion (LLIF) procedure named as XOLIF and compared the efficacy and safety with traditional LLIF procedures. METHODS: Patients were divided into XLIF, OLIF, and XOLIF group according to the surgical approach. Cases of psoas major and vascular space stenosis, psoas major muscle elevation, psoas major muscle hypertrophy, and high iliac crest were recorded. Basic information, composition ratio of specific cases, Visual analog scale (VAS), Oswestry Disability Index (ODI), interbody fusion rate and complications were compared between the 3 groups. RESULTS: The study included 156 cases of L4-5 LLIF. There was no statistical difference in age, gender, BMI among the three groups. Cases with stenosis between psoas muscle and artery accounted for 11.8 and 18.4% of the XLIF and XOLIF group, respectively, while no case of this type had undergone OLIF surgery, the difference was statistically significant (P < 0.05). The proportions of high iliac crest cases in the OLIF and XOLIF group were 12.5 and 18.4%, respectively, while the XLIF group with vertical approach is not suitable for cases with high iliac crest. The postoperative VAS and ODI of the three groups were significantly improved compared with those before operation. There were 51 cases (32.7%) of complications including 21cases in XLIF group, 20 cases in OLIF Group and 10 cases in XOLIF group. XOLIF group has more advantages in reducing lumbar plexus injury and the risk of vascular injury. CONCLUSIONS: XOLIF showed good clinical efficacy and technical advantages with a low incidence of intraoperative and postoperative complications, especially in the specific cases. BioMed Central 2022-03-07 /pmc/articles/PMC8903737/ /pubmed/35255886 http://dx.doi.org/10.1186/s12891-022-05138-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Li, Jiaqi
Sun, Yapeng
Guo, Lei
Zhang, Fei
Ding, Wenyuan
Zhang, Wei
Efficacy and safety of a modified lateral lumbar interbody fusion in L4-5 lumbar degenerative diseases compared with traditional XLIF and OLIF: a retrospective cohort study of 156 cases
title Efficacy and safety of a modified lateral lumbar interbody fusion in L4-5 lumbar degenerative diseases compared with traditional XLIF and OLIF: a retrospective cohort study of 156 cases
title_full Efficacy and safety of a modified lateral lumbar interbody fusion in L4-5 lumbar degenerative diseases compared with traditional XLIF and OLIF: a retrospective cohort study of 156 cases
title_fullStr Efficacy and safety of a modified lateral lumbar interbody fusion in L4-5 lumbar degenerative diseases compared with traditional XLIF and OLIF: a retrospective cohort study of 156 cases
title_full_unstemmed Efficacy and safety of a modified lateral lumbar interbody fusion in L4-5 lumbar degenerative diseases compared with traditional XLIF and OLIF: a retrospective cohort study of 156 cases
title_short Efficacy and safety of a modified lateral lumbar interbody fusion in L4-5 lumbar degenerative diseases compared with traditional XLIF and OLIF: a retrospective cohort study of 156 cases
title_sort efficacy and safety of a modified lateral lumbar interbody fusion in l4-5 lumbar degenerative diseases compared with traditional xlif and olif: a retrospective cohort study of 156 cases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903737/
https://www.ncbi.nlm.nih.gov/pubmed/35255886
http://dx.doi.org/10.1186/s12891-022-05138-7
work_keys_str_mv AT lijiaqi efficacyandsafetyofamodifiedlaterallumbarinterbodyfusioninl45lumbardegenerativediseasescomparedwithtraditionalxlifandolifaretrospectivecohortstudyof156cases
AT sunyapeng efficacyandsafetyofamodifiedlaterallumbarinterbodyfusioninl45lumbardegenerativediseasescomparedwithtraditionalxlifandolifaretrospectivecohortstudyof156cases
AT guolei efficacyandsafetyofamodifiedlaterallumbarinterbodyfusioninl45lumbardegenerativediseasescomparedwithtraditionalxlifandolifaretrospectivecohortstudyof156cases
AT zhangfei efficacyandsafetyofamodifiedlaterallumbarinterbodyfusioninl45lumbardegenerativediseasescomparedwithtraditionalxlifandolifaretrospectivecohortstudyof156cases
AT dingwenyuan efficacyandsafetyofamodifiedlaterallumbarinterbodyfusioninl45lumbardegenerativediseasescomparedwithtraditionalxlifandolifaretrospectivecohortstudyof156cases
AT zhangwei efficacyandsafetyofamodifiedlaterallumbarinterbodyfusioninl45lumbardegenerativediseasescomparedwithtraditionalxlifandolifaretrospectivecohortstudyof156cases